共 155 条
[1]
Guy S(2015)Limitation of the activated partial thromboplastin time as a monitoring method of the direct thrombin inhibitor argatroban Int J Lab Hematol 37 834-843
[2]
Kitchen S(2005)Is the activated clotting time dangerous? Anesthesiology 103 904-904
[3]
Maclean R(2020)Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO Crit Care 24 19-1682
[4]
Van Veen JJ(2021)Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017 BMC Public Health 21 401-145
[5]
Avidan MS(2021)Updates in anticoagulation therapy monitoring Biomedicines 9 262-1197
[6]
Despotis GJ(2010)Medication errors in acute cardiovascular and stroke patients: a scientific statement from the American Heart Association Circulation 121 1664-11
[7]
Chlebowski MM(2017)Understanding how low-socioeconomic status households cope with health shocks: An analysis of multi-sector linked data Ann Am Acad Pol Soc Sci 669 125-991
[8]
Baltagi S(2021)Performance evaluation of coaguchek pro II in comparison with coaguchek XS plus and sta-r Max using a sta-neoplastine CI plus Int J Lab Hematol 43 1191-199
[9]
Carlson M(2021)Capillary flow control in lateral flow assays via delaminating timers Sci. Adv. 7 eabf9833-4041
[10]
Levy JH(2021)Paper-based microfluidics: Simplified fabrication and assay methods Sens Actuators B Chem 336 129681-537